Global Viral Infections Market Analysis 2016 - Forecast to 2022

  • ID: 3845852
  • Report
  • Region: Global
  • 133 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Viral Infections". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Viral Infections Market by Disease Type
5.1 Introduction
5.2 Rotavirus
5.2.1 Rotateq
5.2.2 Rotarix
5.3 Hemorrhagic Fevers
5.3.1 Arena Viruses
5.3.2 Bunya Viruses
5.3.3 Filo Viruses
5.3.4 Flavi Viruses
5.4 Varicella Viruses
5.4.1 Chicken Pox
5.4.2 Shingles
5.5 Opportunistic Viral Infections
5.5.1 Cytomegalovirus
5.5.2 Kaposi's Sarcoma (KS)
5.6 Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection
5.7 Herpes Viruses
5.8 Common Pediatric Viral Infections
5.8.1 Poliomyelitis
5.8.2 Otitis Media (Ear Infections)
5.8.3 Measles, Mumps, Rubella
5.8.4 Diphtheria, Tetanus, Pertussis (DTP)
5.8.5 Croup
5.9 Upper Respiratory Viruses
5.9.1 Common Cold
5.9.2 Sinusitosis
5.9.3 Respiratory Syncytial Virus (RSV)
5.10 Human Papillomavirus (HPV) Infection
5.11 Hiv/Aids
5.12 Hepatitis
5.12.1 Hepatitis A
5.12.2 Hepatitis B
5.12.3 Hepatitis C
5.13 Tuberculosis (TB)
5.14 Crutzfeldt-Jakob Disease (CJD)
5.15 Influenza
5.16 Entroviruses
5.16.1 Coxsackie Viruses
5.17 Other Disease Types

6 Viral Infections Market by End User
6.1 Introduction
6.2 Hospitals Laboratories
6.3 Physician office Labs
6.4 Reference Labs
6.5 Academics Labs
6.6 Others End Users

7 Geographical Segmentation
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 RoW
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Vendor Landscaping
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiles
9.1 Baxter International Inc.
9.1.1 Business Overview
9.1.2 SWOT Analysis
9.1.3 Financial Overview
9.1.4 Strategy
9.1.5 Key Activities
9.2 Bristol-Myers Squibb
9.3 Johnson & Johnson
9.4 Merck & Co., Inc.
9.5 Novartis International AG
9.6 Pfizer Inc.
9.7 Roche Holding AG
9.8 Crucell N.V.
9.9 Vertex Pharmaceuticals
9.10 Sanofi Pasteur
9.11 Amyris Biotechnologies
9.12 Cipla Limited
9.13 Gilead Sciences, Inc.
9.14 Holley Pharmaceuticals
9.15 IPCA Laboratories
9.16 Pidi Standard (holdings) Limited
9.17 Solvay S.A.
9.18 AR Scientific, Inc.
9.19 AstraZeneca plc
9.20 GlaxoSmithKline plc
10 Appendix
11 Disclaimer

List of Tables
Table 1 Global Viral Infections Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Viral Infections Market Analysis, by Disease Type, 2013-2022 ($MN)
Table 3 Global Rotavirus Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Rotavirus Market Analysis, by End User, 2013-2022 ($MN)
Table 5 Global Hemorrhagic Fevers Market Analysis, by Region, 2013-2022 ($MN)
Table 6 Global Hemorrhagic Fevers Market Analysis, by End User, 2013-2022 ($MN)
Table 7 Global Varicella Viruses Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Varicella Viruses Market Analysis, by End User, 2013-2022 ($MN)
Table 9 Global Opportunistic Viral Infections Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Opportunistic Viral Infections Market Analysis, by End User, 2013-2022 ($MN)
Table 11 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection Market Analysis, by End User, 2013-2022 ($MN)
Table 13 Global Herpes Viruses Market Analysis, by Region, 2013-2022 ($MN)
Table 14 Global Herpes Viruses Market Analysis, by End User, 2013-2022 ($MN)
Table 15 Global Common Pediatric Viral Infections Market Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Common Pediatric Viral Infections Market Analysis, by End User, 2013-2022 ($MN)
Table 17 Global Upper Respiratory Viruses Market Analysis, by Region, 2013-2022 ($MN)
Table 18 Global Upper Respiratory Viruses Market Analysis, by End User, 2013-2022 ($MN)
Table 19 Global Human Papillomavirus (HPV) Infection Market Analysis, by Region, 2013-2022 ($MN)
Table 20 Global Human Papillomavirus (HPV) Infection Market Analysis, by End User, 2013-2022 ($MN)
Table 21 Global Hiv/Aids Market Analysis, by Region, 2013-2022 ($MN)
Table 22 Global Hiv/Aids Market Analysis, by End User, 2013-2022 ($MN)
Table 23 Global Hepatitis Market Analysis, by Region, 2013-2022 ($MN)
Table 24 Global Hepatitis Market Analysis, by End User, 2013-2022 ($MN)
Table 25 Global Tuberculosis (TB) Market Analysis, by Region, 2013-2022 ($MN)
Table 26 Global Tuberculosis (TB) Market Analysis, by End User, 2013-2022 ($MN)
Table 27 Global Crutzfeldt-Jakob Disease (CJD) Market Analysis, by Region, 2013-2022 ($MN)
Table 28 Global Crutzfeldt-Jakob Disease (CJD) Market Analysis, by End User, 2013-2022 ($MN)
Table 29 Global Influenza Market Analysis, by Region, 2013-2022 ($MN)
Table 30 Global Influenza Market Analysis, by End User, 2013-2022 ($MN)
Table 31 Global Entroviruses Market Analysis, by Region, 2013-2022 ($MN)
Table 32 Global Entroviruses Market Analysis, by End User, 2013-2022 ($MN)
Table 33 Global Other Disease Types Market Analysis, by Region, 2013-2022 ($MN)
Table 34 Global Other Disease Types Market Analysis, by End User, 2013-2022 ($MN)
Table 35 Global Viral Infections Market Analysis, by End User, 2013-2022 ($MN)
Table 36 Global Hospitals Laboratories Market Analysis, by Region, 2013-2022 ($MN)
Table 37 Global Hospitals Laboratories Market Analysis, by Disease Type, 2013-2022 ($MN)
Table 38 Global Physician office Labs Market Analysis, by Region, 2013-2022 ($MN)
Table 39 Global Physician office Labs Market Analysis, by Disease Type, 2013-2022 ($MN)
Table 40 Global Reference Labs Market Analysis, by Region, 2013-2022 ($MN)
Table 41 Global Reference Labs Market Analysis, by Disease Type, 2013-2022 ($MN)
Table 42 Global Academics Labs Market Analysis, by Region, 2013-2022 ($MN)
Table 43 Global Academics Labs Market Analysis, by Disease Type, 2013-2022 ($MN)
Table 44 Global Others End Users Market Analysis, by Region, 2013-2022 ($MN)
Table 45 Global Others End Users Market Analysis, by Disease Type, 2013-2022 ($MN)

Note: Regional tables are presented in the similar manner as the above
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll